A client with nephrotic syndrome is undergoing a blood test to assess serum lipid levels. What is the rationale for monitoring lipid levels in this client?

A. Incorrect. Decreased serum albumin levels may contribute to fluid overload and hypertension in nephrotic syndrome, but they are not the primary indicators of these complications.

B. Incorrect. A decreased serum albumin level alone does not confirm the presence of proteinuria, which requires additional tests, such as a 24-hour urine collection for protein quantification.

C. Incorrect. Decreased serum albumin levels are not directly related to the presence of renal vein thrombosis, although nephrotic syndrome can increase the risk of thromboembolic events.

D. Correct. In nephrotic syndrome, the glomerular damage results in significant proteinuria, leading to decreased serum albumin levels. The loss of albumin in the urine contributes to hypoalbuminemia, a hallmark feature of nephrotic syndrome.

A. Incorrect. Monitoring lipid levels is not primarily aimed at identifying liver dysfunction in clients with nephrotic syndrome.

B. Incorrect. While nephrotic syndrome can lead to secondary diabetes mellitus in some cases, monitoring lipid levels is not a direct indicator of diabetes.

C. Correct. Nephrotic syndrome is associated with increased levels of lipids, including cholesterol and triglycerides, in the blood (hyperlipidemiA. . Monitoring lipid levels helps detect this common complication of nephrotic syndrome and informs treatment decisions.

D. Incorrect. Monitoring lipid levels is not directly related to evaluating electrolyte imbalances in clients with nephrotic syndrome. Electrolyte imbalances are typically assessed through separate blood tests.

QUESTIONS